Amazing portfolio, crazy pace - Recensione dipendente - Director presso AstraZeneca

4,0
7 set 2025
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Inspiring science and portfolio and senior leadership v good

Svantaggi

Speed and pace is a little crazy and can undermine strategy

Esplora altre recensioni su AstraZeneca

5,0
25 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good products, great oncology pipeline

Svantaggi

Global leaders moving to US that have limited understanding of US environment

4,0
29 giu 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Lots to learn with multiple launches and focus on AI

Svantaggi

heavy middle layer slows down decision making

Vedi recensioni per: Utile|Valutazione|Data|Tutto